Primerry, a paediatric healthcare startup, has raised Rs. 7.1 crore in a pre-seed funding round. The investment includes participation from Ashish Kacholia, Lashit Sanghvi, Mohit Sadaani, Hitesh Dhingra, Ajay Mehra, Samir Palod and select family offices.

The Mumbai-based startup was founded by Rushabh Nandu and Dr. Nihar Parekh.

It wants to make everyday healthcare simpler for parents by developing products designed specifically for children.

What Primerry is building

As per Newzchain, Primerry is focusing on paediatric health and wellness products rather than general healthcare items for all age groups. Its reported approach is centred on clean-label and clinically tested formulations for children’s everyday needs.

The company plans to launch an initial range of eight products. These products are expected to be priced between Rs. 499 and Rs. 1,499, placing them in the premium daily-care segment.

The startup has also introduced PocDoc, a customizable carry case designed to hold Primerry’s healthcare products. This could be useful for parents who want to keep basic child-care essentials organized while travelling or moving between home, school and medical appointments.

How the funding will be used

Primerry plans to use the new capital in three important areas.

• The first is research and development. Paediatric products need careful formulation, safety checks and age-appropriate use instructions. Funding will help Primerry strengthen its product pipeline and improve its clinical and research capabilities.
• The second priority is hiring. At the pre-seed stage, building the founding team is important because the company needs people across product development, medical research, operations, marketing and supply-chain management.
• The third area is distribution. Primerry plans to begin with its own direct-to-consumer platform. It also expects to enter quick-commerce channels within its first year, allowing parents to order selected products more quickly.

The startup is also planning an offline presence through pharmacies, paediatric clinics and speciality stores for mothers and babies. It will initially focus on metropolitan and Tier I cities before considering a wider expansion.

Why the business model matters

Parents often look for healthcare products that are easy to understand, suitable for children and available through trusted channels. Primerry is trying to bring these needs together through a specialized product range and an omnichannel model.

For example, a parent may discover a product online, reorder it through a quick-commerce platform and later find it at a nearby pharmacy or paediatric clinic. This combination of online convenience and offline trust can be useful in the child wellness category.

However, Primerry will compete with established paediatric wellness, personal-care and over-the-counter brands. Its challenge will be to prove that its products offer clear value, maintain consistent quality and earn the confidence of both parents and healthcare professionals.

What comes next for Primerry

As per Scoopearth, the new funding gives Primerry the resources to move from product development to wider commercial execution. Its immediate goals include completing the eight-product range, building a stronger team, launching its digital sales channel and developing retail partnerships.

At this early stage, the company’s progress will be measured by product acceptance, repeat purchases, distribution reach and trust among parents.

Conclusion with key takeaways

Primerry has raised Rs. 7.1 crore in pre-seed funding to build a specialized paediatric healthcare business. Founded by Rushabh Nandu and Dr. Nihar Parekh, the startup plans to launch eight products priced between Rs. 499 and Rs. 1,499.

The money will support research and development, team building and expansion across online and offline channels. Primerry’s larger aim is to make everyday child healthcare products more organized, accessible and suited to the needs of Indian families.

W Health Ventures has closed its second fund at Rs. 700 crore, and the number is only part of the story. What makes this raise interesting is the way the fund plans to work. Instead of simply backing startups after they are already built, W Health Ventures wants to create healthcare companies from the ground up.

The Mumbai-based firm says Fund II will help it build 8-10 companies over the next four years. W Health Ventures says it was founded in 2021, and its leadership is headed by Managing Partner Dr. Pankaj Jethwani. The firm focuses on healthcare businesses in India and the US-India corridor.

How this fund is different

Most venture funds invest in startups once the founder already has a product, some traction, and a clear market. W Health Ventures follows a different path. It uses a company-creation model.

In simple terms, the team first studies a healthcare problem closely, tests whether the opportunity is real, and only then brings in the right founder to build the business. The firm says its in-house team of physicians, operators, and technologists spends 12 to 18 months pressure-testing the idea before a company is launched.

That is a slower process, but it also lowers the risk of building the wrong thing. In healthcare, that matters a lot because regulations, patient trust, and execution are all harder than in many other sectors.

Where the money will go

The second fund is aimed at building companies in areas where healthcare systems still have big gaps. W Health Ventures has already shown the kind of spaces it likes to back. Its current portfolio includes companies working in obesity treatment, chronic pain, pediatrics, oncology, and behavioral health.

For example, it has backed Everhope Oncology, which is focused on cancer care, and Everbright Health, which works on advanced mental health treatment in the US. The larger pattern is clear. The fund is interested in problems that are large, difficult, and still underserved.

That makes the strategy easy to understand. If a market has millions of people with a health need, but very few organized solutions, then a fund like this sees both a business opportunity and a public-health opportunity.

Why investors are paying attention

W Health Ventures says its portfolio companies have already reached 25 million patients. That gives the firm some proof that its model can move beyond theory.

The fund also says it wants to keep building in India while serving some problems in the US-India corridor. That cross-border approach is useful because healthcare problems are often similar across markets, but the solutions need local execution.

Another reason the fund stands out is that it is backed by healthcare-linked investors and family offices. That usually helps in a sector where domain knowledge is just as important as capital.

Who it competes with

W Health Ventures does not behave like a standard venture fund, so its closest comparison is not always another VC firm. Still, in the broader healthcare investing space, funds like HealthQuad and Bharat Innovation Fund are part of the same conversation. They also back healthcare and health-tech businesses, but W Health’s company-creation model gives it a more hands-on role from the earliest stage.

That difference matters. One model funds startups. The other helps design and build them.

Conclusion

W Health Ventures’ Rs. 700 crore second fund is a strong signal that healthcare company creation is becoming a serious investment theme in India. The firm is not just looking for the next healthcare startup. It wants to shape the startup itself, then help it grow into a category leader.

For a sector as complex as healthcare, that approach makes sense. The problems are deep, but so is the opportunity.

Key takeaways –

• W Health Ventures has closed Fund II at Rs. 700 crore.
• The firm says it was founded in 2021 and is led by Dr. Pankaj Jethwani.
• Fund II will aim to build 8-10 healthcare companies over the next four years.
• The fund follows a company-creation model, not just a traditional investment model.
• Its focus areas include obesity, chronic pain, pediatrics, oncology, and behavioral health.
• W Health Ventures works across India and the US-India corridor.

Facts Input- Official Fund II announcement